BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Clinical Oncology

The World Journal of Clinical Oncology (WJCO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of oncology.  It was launched on November 10, 2010 and is published bimonthly (6 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage oncologists worldwide to submit manuscripts to the WJCO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJCO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJCO’s acceptance rate: 55%. Submit here >>

2017 Published Issues
1
Editors-in-Chief

Godefridus Peters, PhD, Professor

Indexing/Abstracting

PubMed, PubMed Central, and Scopus.

Journal Metrics

IPP (Impact per Publication) (2015): 3.306; SNIP (Source Normalized Impact per Paper) (2015): 1.241.

ISSN

2218-4333 (online)

Review
Therapeutic management options for stage III non-small cell lung cancer  
Stephanie M Yoon, Talha Shaikh, Mark Hallman
World J Clin Oncol 8(1):1-20. Published online Feb 10, 2017. doi: 10.5306/wjco.v8.i1.1
Three-dimensional bio-printing: A new frontier in oncology research  
Nitin Charbe, Paul A McCarron, Murtaza M Tambuwala
World J Clin Oncol 8(1):21-36. Published online Feb 10, 2017. doi: 10.5306/wjco.v8.i1.21
From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis  
Melissa Bersanelli, Sebastiano Buti
World J Clin Oncol 8(1):37-53. Published online Feb 10, 2017. doi: 10.5306/wjco.v8.i1.37
Basic Study
Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer  
Tia Harmon, Adriana Harbuzariu, Viola Lanier, Crystal C Lipsey, Ward Kirlin, Lily Yang, Ruben R Gonzalez-Perez
World J Clin Oncol 8(1):54-66. Published online Feb 10, 2017. doi: 10.5306/wjco.v8.i1.54
NDRG2 gene copy number is not altered in colorectal carcinoma  
Anders Lorentzen, Cathy Mitchelmore
World J Clin Oncol 8(1):67-74. Published online Feb 10, 2017. doi: 10.5306/wjco.v8.i1.67
Prospective Study
Salient concerns in using analgesia for cancer pain among outpatients: A cluster analysis study  
Salimah H Meghani, George J Knafl
World J Clin Oncol 8(1):75-85. Published online Feb 10, 2017. doi: 10.5306/wjco.v8.i1.75
Case Report
Intermittent facial spasms as the presenting sign of a recurrent pleomorphic adenoma  
Rosalie A Machado, Sami P Moubayed, Azita Khorsandi, Juan C Hernandez-Prera, Mark L Urken
World J Clin Oncol 8(1):86-90. Published online Feb 10, 2017. doi: 10.5306/wjco.v8.i1.86
Difficult endoscopic diagnosis of a pancreatic plasmacytoma: Case report and review of literature  
Nicolas Williet, Radwan Kassir, Muriel Cuilleron, Olivier Dumas, Leslie Rinaldi, Karine Augeul-Meunier, Michèle Cottier, Xavier Roblin, Jean-Marc Phelip
World J Clin Oncol 8(1):91-95. Published online Feb 10, 2017. doi: 10.5306/wjco.v8.i1.91